{ }
001122334455554433221100
001122334455554433221100

Julien Scemama joins SocGen to lead equity private placements in EMEA

Julien Scemama has joined SocGen in Paris as the head of its equity private placements team in EMEA, moving from BNP Paribas in London. With private placements gaining traction as a preferred fundraising method for corporates, banks are bolstering their teams in this area, reflecting a growing trend in private capital.

jp morgan and ubs dominate asia pacific m a advisory rankings 2024

JP Morgan and UBS have emerged as the leading financial advisers for mergers and acquisitions in the Asia-Pacific region for 2024, topping the rankings by value and volume, respectively. JP Morgan advised on deals worth $31.5 billion, while UBS led with 40 transactions, including seven billion-dollar deals, securing a total deal value of $21.1 billion. Moelis & Company and Morgan Stanley followed in the rankings, highlighting a competitive landscape in M&A advisory services.

Moelis and Company Provides Strategic Financial Advisory Services Globally

Moelis & Company is an independent global investment bank that provides strategic financial advisory services to a diverse clientele, including corporations and governments. The firm specializes in mergers and acquisitions, recapitalizations, capital markets transactions, and private fundraising, operating from 23 locations worldwide.
16:15 06.12.2024

Moelis and Company Offers Comprehensive Financial Advisory Services Globally

Moelis & Company is an independent global investment bank that provides strategic financial advisory services to a diverse clientele, including corporations, governments, and financial sponsors. The firm specializes in mergers and acquisitions, recapitalizations, capital market transactions, and corporate finance issues, operating from 23 locations worldwide. It also offers capital markets solutions, acting as a placement agent, advisor, or bookrunner for various fundraising mandates.
16:05 06.12.2024

Moelis and Company Provides Strategic Financial Advisory Services Globally

Moelis & Company is a global, independent investment bank that provides strategic advisory and financial solutions to a diverse clientele, including corporations, governments, and financial sponsors. The firm specializes in mergers and acquisitions (M&A), recapitalizations, capital market transactions, and corporate finance issues, operating from 23 locations worldwide. It also acts as a placement agent and advisor for capital raising mandates, offering comprehensive capital market advice.
16:05 06.12.2024

global payments sells advancedmd for 1.13 billion to focus on core operations

Global Payments is selling its medical software unit, AdvancedMD, to Francisco Partners for $1.13 billion as part of a strategy to streamline operations and focus on core payment processing. The company plans to use some proceeds for a $600 million accelerated stock buyback. AdvancedMD, acquired for $700 million in 2018, provides software services to healthcare facilities in the U.S. The deal is expected to close in the fourth quarter.

moelis and company offers strategic financial advisory services globally

Moelis & Company is an independent global investment bank that provides strategic financial advisory services to a diverse clientele, including corporations and governments. The firm specializes in mergers and acquisitions, recapitalizations, capital markets transactions, and private fundraising, operating from 23 locations worldwide.
15:07 28.10.2024

ubs maintains sell rating on moelis and company investment bank

Moelis & Company is a global independent investment bank that offers strategic financial advisory services to a diverse clientele, including corporations and governments. The firm specializes in mergers and acquisitions, recapitalizations, capital markets transactions, and corporate finance matters, operating from 23 offices worldwide. Recently, UBS reaffirmed its sell rating on the firm.
15:04 28.10.2024

editas seeks partner for gene editing therapy amid strategic shift

Editas Medicine is seeking a partner or considering out-licensing its lead gene editing therapy, reni-cel, aimed at treating sickle cell disease and beta thalassemia. This shift comes as the company pivots from previous strategies and aims to reduce spending while advancing its research. Despite promising preclinical data, Editas faces challenges in bringing reni-cel to market, prompting a focus on in vivo gene editing for future treatments.

jp morgan and ubs dominate apac m and a advisory rankings 2024

JP Morgan and UBS have topped the APAC M&A financial advisory rankings for Q1-Q3 2024, leading in deal value and volume, respectively. JP Morgan advised on transactions worth $17bn, while UBS facilitated 30 deals, totaling $14.4bn in value. Moelis & Company, TD Securities, and Mitsubishi UFJ Financial followed in the value rankings, while Moelis also secured second place in volume.
11:42 21.10.2024
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.